Veritas Medicine and HIV and Hepatitis.com Partner to Give Patients Comprehensive Access to Clinical Trials and Treatment Information

[Guest guest]

Veritas Medicine and HIV and Hepatitis.com Partner to Give Patients

Comprehensive Access to Clinical Trials and Treatment Information

January 23, 2001

CAMBRIDGE, Mass.--(BW HealthWire)--Jan. 22, 2001 via

NewsEdge Corporation - Patients and Physicians Visiting Online Publication

HIV

and Hepatitis.com Can Access Comprehensive, Reliable treatment Information

Veritas Medicine, a comprehensive online clinical trials

and treatment resource for patients, physicians, and pharmaceutical

companies, today announced that it will partner with online publication HIV

and Hepatitis.com, to enable hundreds of thousands of patients and

physicians to access its database of clinical trials and treatment

information on HIV and viral hepatitis. Through visiting

www.hivandhepatitis.com or www.veritasmedicine.com, patients and their

physicians can be matched against relevant new treatments and open trials,

and access groundbreaking, reliable information about the latest treatment

options.

HIV and Hepatitis.com provides HIV and hepatitis patient

communities and their medical and family caregivers with free access to

cutting-edge information about treatments and vaccines. Veritas Medicine,

launched in November 2000, leverages the power of the Internet to connect

chronically ill patients and physicians to potentially life-prolonging

treatments and clinical trials. Through relationships with

physician-scientists affiliated with leading medical research centers,

Veritas Medicine also provides easy to understand, corresponding information

to help patients and their physicians make the most informed choices.

" Our partnership with HIV and Hepatitis.com is extremely

important - AIDS is the 5th leading cause of death among adults between the

ages of 25 - 44, " said Joe Avellone, M.D., CEO of Veritas Medicine. " Through

working with HIV and Hepatitis.com, we are providing patients and their

caregivers with a powerful, highly reliable and personalized way to explore

all relevant options for treating their disease. " Veritas Medicine currently

provides access to 88 clinical trials for HIV/AIDS, as well as information

on 53 new drugs in development.

" Our objectives at HIV and Hepatitis.com are to improve

quality of life, slow disease progression and increase survival among the

millions of people worldwide who live with HIV and viral hepatitis

infection, " said Baker, editor-in-chief and publisher of HIV and

Hepatitis.com. " Our partnership with Veritas Medicine results from a

commitment shared by both organizations to provide patients and caregivers

with free, comprehensive and accurate information that empowers them to make

the best treatment decisions. "

In addition to HIV and Hepatitis.com, Veritas Medicine is

available to millions of users through leading health-related non-profit

organizations and dot-coms, such as AEGIS, MedicineNet.com, Your Doctor.com,

HealthOnline, HepCBC-Hepatitis C Education and Prevention Society, and the

Arthritis National Research Foundation. HIV and Hepatitis.com receives an

average of 20,000 unique visitors each week, and is planning to

significantly expand the content of the site in 2001. The organization will

add four new sections that focus on treatment and testing for HIV and viral

hepatitis, and increased medical expert commentary that will complement the

treatments and trials information available through Veritas Medicine.

About Veritas Medicine

Veritas Medicine, based in Cambridge, Massachusetts, is

the first comprehensive online medical resource developed to address the

needs of patients, physicians and other health care professionals, and

pharmaceutical sponsors - all of whom could benefit from a centralized and

highly secure online resource that provides expert, reliable and up to date

information about clinical trials and innovative treatments. The company is

backed by Burrill & Company, BioAsia's Biotechnology Development Fund II and

E-Health Holdings Fund, Cambridge Incubator, Seaflower Ventures and MDS

Capital.

CONTACT: Veritas Medicine | Beth Spearman | 617-234-1533 |

spearman@... | or | The Portico Group | Kristy

Kozaka/ Waite | 781-698-2402 | kristy@... |

kwaite@...

[Guest guest]

Veritas Medicine and HIV and Hepatitis.com Partner to Give Patients

Comprehensive Access to Clinical Trials and Treatment Information

January 23, 2001

CAMBRIDGE, Mass.--(BW HealthWire)--Jan. 22, 2001 via

NewsEdge Corporation - Patients and Physicians Visiting Online Publication

HIV

and Hepatitis.com Can Access Comprehensive, Reliable treatment Information

Veritas Medicine, a comprehensive online clinical trials

and treatment resource for patients, physicians, and pharmaceutical

companies, today announced that it will partner with online publication HIV

and Hepatitis.com, to enable hundreds of thousands of patients and

physicians to access its database of clinical trials and treatment

information on HIV and viral hepatitis. Through visiting

www.hivandhepatitis.com or www.veritasmedicine.com, patients and their

physicians can be matched against relevant new treatments and open trials,

and access groundbreaking, reliable information about the latest treatment

options.

HIV and Hepatitis.com provides HIV and hepatitis patient

communities and their medical and family caregivers with free access to

cutting-edge information about treatments and vaccines. Veritas Medicine,

launched in November 2000, leverages the power of the Internet to connect

chronically ill patients and physicians to potentially life-prolonging

treatments and clinical trials. Through relationships with

physician-scientists affiliated with leading medical research centers,

Veritas Medicine also provides easy to understand, corresponding information

to help patients and their physicians make the most informed choices.

" Our partnership with HIV and Hepatitis.com is extremely

important - AIDS is the 5th leading cause of death among adults between the

ages of 25 - 44, " said Joe Avellone, M.D., CEO of Veritas Medicine. " Through

working with HIV and Hepatitis.com, we are providing patients and their

caregivers with a powerful, highly reliable and personalized way to explore

all relevant options for treating their disease. " Veritas Medicine currently

provides access to 88 clinical trials for HIV/AIDS, as well as information

on 53 new drugs in development.

" Our objectives at HIV and Hepatitis.com are to improve

quality of life, slow disease progression and increase survival among the

millions of people worldwide who live with HIV and viral hepatitis

infection, " said Baker, editor-in-chief and publisher of HIV and

Hepatitis.com. " Our partnership with Veritas Medicine results from a

commitment shared by both organizations to provide patients and caregivers

with free, comprehensive and accurate information that empowers them to make

the best treatment decisions. "

In addition to HIV and Hepatitis.com, Veritas Medicine is

available to millions of users through leading health-related non-profit

organizations and dot-coms, such as AEGIS, MedicineNet.com, Your Doctor.com,

HealthOnline, HepCBC-Hepatitis C Education and Prevention Society, and the

Arthritis National Research Foundation. HIV and Hepatitis.com receives an

average of 20,000 unique visitors each week, and is planning to

significantly expand the content of the site in 2001. The organization will

add four new sections that focus on treatment and testing for HIV and viral

hepatitis, and increased medical expert commentary that will complement the

treatments and trials information available through Veritas Medicine.

About Veritas Medicine

Veritas Medicine, based in Cambridge, Massachusetts, is

the first comprehensive online medical resource developed to address the

needs of patients, physicians and other health care professionals, and

pharmaceutical sponsors - all of whom could benefit from a centralized and

highly secure online resource that provides expert, reliable and up to date

information about clinical trials and innovative treatments. The company is

backed by Burrill & Company, BioAsia's Biotechnology Development Fund II and

E-Health Holdings Fund, Cambridge Incubator, Seaflower Ventures and MDS

Capital.

CONTACT: Veritas Medicine | Beth Spearman | 617-234-1533 |

spearman@... | or | The Portico Group | Kristy

Kozaka/ Waite | 781-698-2402 | kristy@... |

kwaite@...

[Guest guest]

Veritas Medicine and HIV and Hepatitis.com Partner to Give Patients

Comprehensive Access to Clinical Trials and Treatment Information

January 23, 2001

CAMBRIDGE, Mass.--(BW HealthWire)--Jan. 22, 2001 via

NewsEdge Corporation - Patients and Physicians Visiting Online Publication

HIV

and Hepatitis.com Can Access Comprehensive, Reliable treatment Information

Veritas Medicine, a comprehensive online clinical trials

and treatment resource for patients, physicians, and pharmaceutical

companies, today announced that it will partner with online publication HIV

and Hepatitis.com, to enable hundreds of thousands of patients and

physicians to access its database of clinical trials and treatment

information on HIV and viral hepatitis. Through visiting

www.hivandhepatitis.com or www.veritasmedicine.com, patients and their

physicians can be matched against relevant new treatments and open trials,

and access groundbreaking, reliable information about the latest treatment

options.

HIV and Hepatitis.com provides HIV and hepatitis patient

communities and their medical and family caregivers with free access to

cutting-edge information about treatments and vaccines. Veritas Medicine,

launched in November 2000, leverages the power of the Internet to connect

chronically ill patients and physicians to potentially life-prolonging

treatments and clinical trials. Through relationships with

physician-scientists affiliated with leading medical research centers,

Veritas Medicine also provides easy to understand, corresponding information

to help patients and their physicians make the most informed choices.

" Our partnership with HIV and Hepatitis.com is extremely

important - AIDS is the 5th leading cause of death among adults between the

ages of 25 - 44, " said Joe Avellone, M.D., CEO of Veritas Medicine. " Through

working with HIV and Hepatitis.com, we are providing patients and their

caregivers with a powerful, highly reliable and personalized way to explore

all relevant options for treating their disease. " Veritas Medicine currently

provides access to 88 clinical trials for HIV/AIDS, as well as information

on 53 new drugs in development.

" Our objectives at HIV and Hepatitis.com are to improve

quality of life, slow disease progression and increase survival among the

millions of people worldwide who live with HIV and viral hepatitis

infection, " said Baker, editor-in-chief and publisher of HIV and

Hepatitis.com. " Our partnership with Veritas Medicine results from a

commitment shared by both organizations to provide patients and caregivers

with free, comprehensive and accurate information that empowers them to make

the best treatment decisions. "

In addition to HIV and Hepatitis.com, Veritas Medicine is

available to millions of users through leading health-related non-profit

organizations and dot-coms, such as AEGIS, MedicineNet.com, Your Doctor.com,

HealthOnline, HepCBC-Hepatitis C Education and Prevention Society, and the

Arthritis National Research Foundation. HIV and Hepatitis.com receives an

average of 20,000 unique visitors each week, and is planning to

significantly expand the content of the site in 2001. The organization will

add four new sections that focus on treatment and testing for HIV and viral

hepatitis, and increased medical expert commentary that will complement the

treatments and trials information available through Veritas Medicine.

About Veritas Medicine

Veritas Medicine, based in Cambridge, Massachusetts, is

the first comprehensive online medical resource developed to address the

needs of patients, physicians and other health care professionals, and

pharmaceutical sponsors - all of whom could benefit from a centralized and

highly secure online resource that provides expert, reliable and up to date

information about clinical trials and innovative treatments. The company is

backed by Burrill & Company, BioAsia's Biotechnology Development Fund II and

E-Health Holdings Fund, Cambridge Incubator, Seaflower Ventures and MDS

Capital.

CONTACT: Veritas Medicine | Beth Spearman | 617-234-1533 |

spearman@... | or | The Portico Group | Kristy

Kozaka/ Waite | 781-698-2402 | kristy@... |

kwaite@...

[Guest guest]

Veritas Medicine and HIV and Hepatitis.com Partner to Give Patients

Comprehensive Access to Clinical Trials and Treatment Information

January 23, 2001

CAMBRIDGE, Mass.--(BW HealthWire)--Jan. 22, 2001 via

NewsEdge Corporation - Patients and Physicians Visiting Online Publication

HIV

and Hepatitis.com Can Access Comprehensive, Reliable treatment Information

Veritas Medicine, a comprehensive online clinical trials

and treatment resource for patients, physicians, and pharmaceutical

companies, today announced that it will partner with online publication HIV

and Hepatitis.com, to enable hundreds of thousands of patients and

physicians to access its database of clinical trials and treatment

information on HIV and viral hepatitis. Through visiting

www.hivandhepatitis.com or www.veritasmedicine.com, patients and their

physicians can be matched against relevant new treatments and open trials,

and access groundbreaking, reliable information about the latest treatment

options.

HIV and Hepatitis.com provides HIV and hepatitis patient

communities and their medical and family caregivers with free access to

cutting-edge information about treatments and vaccines. Veritas Medicine,

launched in November 2000, leverages the power of the Internet to connect

chronically ill patients and physicians to potentially life-prolonging

treatments and clinical trials. Through relationships with

physician-scientists affiliated with leading medical research centers,

Veritas Medicine also provides easy to understand, corresponding information

to help patients and their physicians make the most informed choices.

" Our partnership with HIV and Hepatitis.com is extremely

important - AIDS is the 5th leading cause of death among adults between the

ages of 25 - 44, " said Joe Avellone, M.D., CEO of Veritas Medicine. " Through

working with HIV and Hepatitis.com, we are providing patients and their

caregivers with a powerful, highly reliable and personalized way to explore

all relevant options for treating their disease. " Veritas Medicine currently

provides access to 88 clinical trials for HIV/AIDS, as well as information

on 53 new drugs in development.

" Our objectives at HIV and Hepatitis.com are to improve

quality of life, slow disease progression and increase survival among the

millions of people worldwide who live with HIV and viral hepatitis

infection, " said Baker, editor-in-chief and publisher of HIV and

Hepatitis.com. " Our partnership with Veritas Medicine results from a

commitment shared by both organizations to provide patients and caregivers

with free, comprehensive and accurate information that empowers them to make

the best treatment decisions. "

In addition to HIV and Hepatitis.com, Veritas Medicine is

available to millions of users through leading health-related non-profit

organizations and dot-coms, such as AEGIS, MedicineNet.com, Your Doctor.com,

HealthOnline, HepCBC-Hepatitis C Education and Prevention Society, and the

Arthritis National Research Foundation. HIV and Hepatitis.com receives an

average of 20,000 unique visitors each week, and is planning to

significantly expand the content of the site in 2001. The organization will

add four new sections that focus on treatment and testing for HIV and viral

hepatitis, and increased medical expert commentary that will complement the

treatments and trials information available through Veritas Medicine.

About Veritas Medicine

Veritas Medicine, based in Cambridge, Massachusetts, is

the first comprehensive online medical resource developed to address the

needs of patients, physicians and other health care professionals, and

pharmaceutical sponsors - all of whom could benefit from a centralized and

highly secure online resource that provides expert, reliable and up to date

information about clinical trials and innovative treatments. The company is

backed by Burrill & Company, BioAsia's Biotechnology Development Fund II and

E-Health Holdings Fund, Cambridge Incubator, Seaflower Ventures and MDS

Capital.

CONTACT: Veritas Medicine | Beth Spearman | 617-234-1533 |

spearman@... | or | The Portico Group | Kristy

Kozaka/ Waite | 781-698-2402 | kristy@... |

kwaite@...